Identifying Novel Osteoanabolic Targets for Bone Regeneration: A Systems Genetics Approach to Optimizing Functional Recovery
PM&R · 2026-11 · 18 (S3)
DOI: 10.1002/pmrj.113_70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Lucia M. Wagner und 2 weiteren Autor:innen.
Abstract (Originalsprache)
used lower corticosteroid doses for knee injections (mean [SD], 38 [28] mg) compared to orthopedic surgeons (54 [39] mg), radiologists (45 [35] mg), primary care clinicians (49 [32] mg), rheumatologists (47 [26] mg), and anesthesiologists (46 [36] mg).This pattern was similar, though less dramatic, for shoulder injections (mean [SD], 46 [28] mg for physiatrists versus 55 [34] mg for orthopedic surgeons) but not hip injections (mean dose range across specialties 51-57 mg, physiatrists 56 mg).Conclusions: On average, older adults who received a corticosteroid injection for symptomatic knee or shoulder osteoarthritis had lower per-injection corticosteroid exposure if the injection was performed by a physiatrist rather than another specialist.Additional research is needed to explore the safety and effectiveness implications of corticosteroid dosing regimens.
Zitieren
APA
Wagner, L. M., Calabrese, G., & Farber, C. (2026). Identifying Novel Osteoanabolic Targets for Bone Regeneration: A Systems Genetics Approach to Optimizing Functional Recovery. PM&R, 18(S3). https://doi.org/10.1002/pmrj.113_70259
Vancouver
Wagner LM, Calabrese G, Farber C. Identifying Novel Osteoanabolic Targets for Bone Regeneration: A Systems Genetics Approach to Optimizing Functional Recovery. PM&R. 2026;18(S3). doi:10.1002/pmrj.113_70259
BibTeX
@article{Wagner2026,
author = {Wagner, Lucia M. and Calabrese, Gina and Farber, Charles},
title = {Identifying Novel Osteoanabolic Targets for Bone Regeneration: A Systems Genetics Approach to Optimizing Functional Recovery},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S3},
doi = {10.1002/pmrj.113_70259}
}
EUVIMED